Truist Financial’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,876
Closed -$435K 2996
2026
Q1
$435K Buy
10,876
+2,455
+29% +$116K ﹤0.01% 2147
2025
Q4
$379K Buy
8,421
+331
+4% +$15.3K ﹤0.01% 2195
2025
Q3
$361K Buy
8,090
+1,920
+31% +$91.9K ﹤0.01% 2205
2025
Q2
$297K Buy
6,170
+439
+8% +$19.1K ﹤0.01% 2222
2025
Q1
$230K Buy
5,731
+271
+5% +$11.4K ﹤0.01% 2291
2024
Q4
$250K Sell
5,460
-68
-1% -$3.04K ﹤0.01% 2263
2024
Q3
$259K Sell
5,528
-4,981
-47% -$227K ﹤0.01% 2221
2024
Q2
$444K Sell
10,509
-2,178
-17% -$95.5K ﹤0.01% 2045
2024
Q1
$561K Buy
+12,687
New +$578K ﹤0.01% 1902
2020
Q2
Sell
-22,733
Closed -$1M 2556
2020
Q1
$1M Sell
22,733
-13,839
-38% -$541K ﹤0.01% 1255
2019
Q4
$1.31M Buy
+36,572
New +$1.36M ﹤0.01% 1326

Other funds holding QGEN

Truist Financial's QGEN Position: Q2 2026 in Review

Truist Financial sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 10,876 shares — an estimated $435K sold.

Truist Financial first reported a position in QGEN in Q4 2019 and held it in 11 quarters. The position peaked at $1.31M in Q4 2019. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Truist Financial reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Truist Financial sold 10,876 Qiagen shares in Q2 2026, an estimated $435K.
  • Truist Financial first reported a position in Qiagen in Q4 2019 and held it in 11 quarters.
  • Truist Financial's Qiagen position peaked at $1.31M in Q4 2019.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.